Zero Candida Technologies, Inc. (TSXV:ZCT)
0.1050
0.00 (0.00%)
Nov 17, 2026, 3:43 PM EST
Zero Candida Technologies Company Description
Zero Candida Technologies, Inc., a FemTech company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis.
It offers Zero Candida, a novel diagnostic and therapeutic technology platform that collect and transmit treatment data to the attending physician in real time for assessment, treatment personalization, and monitoring, as well as developing SMART, a vaginal diagnostic device for women suffering from candidiasis.
The company was incorporated in 2021 and is based in Vancouver, Canada.
Zero Candida Technologies, Inc.
| Country | Canada |
| Founded | 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Eli Ben-Haroosh |
Contact Details
Address: 666 Burrard Street Vancouver, BC V6C 3P6 Canada | |
| Phone | 647 874 3767 |
| Website | zero-candida.com |
Stock Details
| Ticker Symbol | ZCT |
| Exchange | TSX Venture Exchange |
| Reporting Currency | CAD |
| ISIN Number | CA9894831028 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Eli Ben-Haroosh | Founder, Chief Executive Officer and Director |
| Dr. Asher Holzer Ph.D. | Co-Founder and Director |
| Dr. Irene Zaiton M.B.A., Ph.D. | Vice President of Operations and Research |
| Tammy Dvir Bar-On | Vice President Product and Marketing |
| Yosh Dolberg | Senior Vice President of Development and Engineering |